USPTO serial 79373294
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lisa C. Pavento
Lisa C. Pavento Meunier Carlin & Curfman LLC999 Peachtree St. NE, Suite 1300Atlanta, GA 30309United States| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Research apparatus and instruments for laboratories, namely, apparatus for detecting proteins and genetic biomarker sequences; Research apparatus and instruments for laboratories, namely, apparatus for detecting proteins; Research apparatus and instruments for laboratories, namely, apparatus for detecting human, animal, viral, bacterial and toxin proteins; Research apparatus and instruments for laboratories, namely, apparatus for detecting genetic biomarker sequences; Research apparatus and instruments for laboratories, namely, apparatus for detecting genetic biomarker sequences, namely, DNA, SNPs (single-nucleotide polymorphisms), ESTs (expressed sequence tags), mRNA (messenger RNA), tRNA (transfer RNA), iRNA (informational RNA), rRNA (ribosomal RNA), miRNAs (micro RNAs), and mitochondrial DNA; scientific apparatus and instruments, namely, apparatus for detecting proteins and genetic biomarker sequences for use in research; scientific apparatus and instruments, namely, apparatus for detecting proteins for use in research; scientific apparatus and instruments, namely, apparatus for detecting human, animal, viral, bacterial and toxin proteins for use in research; scientific apparatus and instruments, namely, apparatus for detecting genetic biomarker sequences for use in research; scientific apparatus and instruments, namely, apparatus for detecting genetic biomarker sequences, namely, DNA, SNPs (single-nucleotide polymorphisms), ESTs (expressed sequence tags), mRNA (messenger RNA), tRNA (transfer RNA), iRNA (informational RNA), rRNA (ribosomal RNA), miRNAs (micro RNAs), and mitochondrial DNA for use in research | ACTIVE | — |
| 010 | Apparatus for analysis for medical or veterinary use, namely, medical and veterinary instruments for analyzing proteins and genetic biomarker sequences; Apparatus for analysis for medical or veterinary use, namely, medical and veterinary instruments for analyzing proteins and genetic biomarker sequences in human and animal samples; Apparatus for analysis for medical or veterinary use, namely, medical and veterinary instruments for analyzing human, animal, viral, bacterial and toxin proteins; Apparatus for analysis for medical or veterinary use, namely, medical and veterinary instruments for analyzing genetic biomarker sequences; Apparatus for analysis for medical or veterinary use, namely, medical and veterinary instruments for analyzing genetic biomarker sequences, namely, DNA, SNPs (single-nucleotide polymorphisms), ESTs (expressed sequence tags), mRNA (messenger RNA), tRNA (transfer RNA), iRNA (informational RNA), rRNA (ribosomal RNA), miRNAs (micro RNAs), and mitochondrial DNA; medical, dental and veterinary apparatus and instruments, namely, medical, dental and veterinary instruments for detecting proteins and genetic biomarker sequences; medical, dental and veterinary apparatus and instruments, namely, medical, dental and veterinary instruments for detecting proteins and genetic biomarker sequences in human and animal samples; medical, dental and veterinary apparatus and instruments, namely, medical, dental and veterinary instruments for detecting human, animal, viral, bacterial and toxin proteins; medical, dental and veterinary apparatus and instruments, namely, medical, dental and veterinary instruments for detecting genetic biomarker sequences; medical, dental and veterinary apparatus and instruments, namely, medical, dental and veterinary instruments for detecting genetic biomarker sequences, namely, DNA, SNPs (single-nucleotide polymorphisms), ESTs (expressed sequence tags), mRNA (messenger RNA), tRNA (transfer RNA), iRNA (informational RNA), rRNA (ribosomal RNA), miRNAs (micro RNAs), and mitochondrial DNA | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 15, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 15, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 29, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 29, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 29, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 4, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 4, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 1, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 1, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 1, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 8, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 20, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 20, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 8, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 8, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 1, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 7, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |